Clinical Trial Update: Booster Dose of COVID-19 Vaccine for Kidney Transplant Recipients Without Adequate Humoral Response [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updates booster dosing of a COVID-19 vaccine in kidney transplant recipients who lacked an adequate humoral response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunosuppression
• Respiratory Distress Syndrome

Snippet

Sponsor: dafna yahav | Conditions: COVID-19 Acute Respiratory Distress Syndrome, Immunosuppression | Phase 4 | Status: UNKNOWN